Afuco™ Anti-Human S100A4 ADCC Therapeutic Antibody (LK-1), ADCC Enhanced
Anti-S100A4 ADCC Enhanced Antibody (LK-1) is an ADCC enhanced antibody produced by our Afuco™ platform. LK-1 is a first-in-class humanized monoclonal antibody directed against S100A4, a soluble protein acting as a key target in the three tumor compartments, and therefore having anti-tumor, anti-metastasis, and anti-angiogenic activities in one drug.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-524CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | S100A4 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at -20°C. Avoid multiple freeze/thaw cycles. |